Related Experiment Videos
Contrast echography of the eye and orbit
Summary
SH U 454, an echocontrast agent, shows promise for ophthalmic ultrasound diagnostics. It enhances visualization in the eye and allows measurement of intraocular blood flow in dogs.
Area of Science:
- Ophthalmic Ultrasound
- Medical Imaging
- Veterinary Ophthalmology
Background:
- SH U 454 is a novel echocontrast agent initially developed for echocardiography.
- Potential applications beyond cardiac imaging are being explored.
- Ophthalmic ultrasound diagnostics can benefit from advanced contrast agents.
Purpose of the Study:
- To investigate the utility of SH U 454 in ophthalmic ultrasound diagnostics.
- To evaluate the contrast enhancement effects of SH U 454 in ocular tissues.
- To assess the feasibility of determining intraocular blood flow parameters using SH U 454.
Main Methods:
- Administration of SH U 454 in canine ocular models.
- Ophthalmic ultrasound imaging to assess contrast enhancement.
- Digital image processing techniques for quantitative analysis.
- Measurement of intraocular blood flow parameters.
Main Results:
- SH U 454 demonstrated significant contrast enhancement in the orbit, choroid, and ciliary body.
- The agent facilitated the determination of intraocular blood flow parameters in dogs.
- Digital image processing enabled precise measurement of these effects.
Conclusions:
- SH U 454 shows potential as an effective echocontrast agent for ophthalmic ultrasound.
- The agent can enhance visualization and enable quantitative blood flow assessment in the eye.
- Further research may validate its use in veterinary and potentially human ophthalmology.